The pitches for MGM and Talon Energy focus on established, physical asset-heavy businesses that are perceived as undervalued. Their value is expected to be unlocked by specific future events: MGM by international expansion and a takeover bid, and Talon by the AI-driven surge in electricity demand.
The Talon Energy thesis is a prime example of a second-order effect of the AI boom. The massive, unanticipated power requirements of data centers are creating a structural shift in the energy market, creating significant opportunities for providers of reliable baseload power like nuclear and natural gas.
Actis Oncology (radiopharmaceuticals) and GeoNet (decentralized RTK network) represent investments in novel technology platforms. Their potential valuations are immense, but contingent on future success—clinical trial data for Actis and continued network adoption for GeoNet—making them binary, lottery-ticket-like opportunities.
The MGM pitch is heavily influenced by the actions of activist investor Barry Diller, whose 26% stake and recent takeover bid have put the company 'in play'. This external pressure acts as a major catalyst, forcing the market to re-evaluate the company's intrinsic value and creating a specific, time-sensitive investment opportunity.
Keep pulling the thread on Bristol Myers Squibb.